Christopher Twelves Selected Research

Christopher Twelves Research Topics

8	Breast Neoplasms (Breast Cancer) 12/2015 - 07/2004
3	Neoplasms (Cancer) 01/2014 - 06/2009
2	Neutropenia 01/2021 - 12/2015
2	Colorectal Neoplasms (Colorectal Cancer) 06/2009 - 12/2002
1	Stomatitis 01/2021
1	Vomiting 01/2021
1	Anemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Diarrhea 01/2021
1	Leukopenia 01/2021
1	Nausea 01/2021
1	Obesity 12/2015
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Disease Progression 05/2011
1	Breast Cancer 3 06/2009

2	Capecitabine (Xeloda)FDA Link 01/2021 - 12/2002
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 09/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 12/2002
1	Sodium Glutamate (Accent)IBA 01/2021
1	eribulin FDA Link 12/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013
1	1- (ethoxycarbonyloxymethyl)- 5- fluorouracilIBA 09/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2013
1	Methotrexate (Mexate)FDA LinkGeneric 09/2013
1	Epirubicin (Ellence)FDA LinkGeneric 09/2013
1	Taxoids (Taxanes)IBA 05/2011
1	PolymersIBA 06/2009
1	N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateIBA 06/2009
1	AnthracyclinesIBA 06/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009
1	XELOXIBA 12/2002
1	AT 130IBA 12/2002
1	Leucovorin (Folinic Acid)FDA Link 12/2002